Skip to main content
VARSITY: Better histologic outcomes with vedolizumab than adalimumab in UC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
VARSITY: Better histologic outcomes with vedolizumab than adalimumab in UC
User login
Username
Password
Reset your password
Concept
Lead
score
Ulcerative Colitis
1
1
Colitis
0
0.64
Inflammatory Bowel Disease
0
0.63
Histology
0
0.48
Remission
0
0.48
Biologic Therapy
0
0.16
Clinical Research
0
0.16
Corticosteroids
0
0.16
Crohn Disease
0
0.16
Endoscopy
0
0.16
Europe
0
0.16
Hospital
0
0.16
Specialty
Lead
score
Gastroenterology
1
1
Internal Medicine
0
0.9
Family Medicine/Primary Care
0
0.8